Class Action Reminder from Pomerantz LLP for Investors of Cytokinetics, Incorporate – CYTK

NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate ("Cytokinetics" or the "Company") (NASDAQ:CYTK).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]

Class Action Now Underway by Pomerantz LLP Against Jasper Therapeutics, Inc. – JSPR

NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010,

Pomerantz LLP Issues Important Reminder to Shareholders in Avantor, Inc. of Class Action – AVTR

NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avantor, Inc. ("Avantor" or the "Company") (NYSE:AVTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pomerantz LLP Advises Investors of Class Action Against James Hardie Industries plc – JHX

NEW YORK CITY, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc ("James Hardie" or the "Company") (NYSE:JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by

BrainXell Showcases Pioneering iPSC Research and Promising In Vivo Data for BXT-110 for Parkinson’s Disease at the 2025 Society for Neuroscience Annual Meeting

BrainXell, Inc. today announced that data will be presented during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego, highlighting new breakthroughs in human iPSC-derived cell models and regenerative neuroscience. https://mma.prnewswire.com/media/2717924/Brainxell_Logo.jpg These presentations underscore BrainXell's focus on scientific discovery and clinical translation, spanning scalable cell-based assays, advanced disease modeling, and

Class Action Announcement for Firefly Aerospace Inc. (FLY): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Firefly Aerospace Inc.

(NasdaqGM:FLY), RADNOR, Pa., Nov. 15, 2025 (GLOBE NEWSWIRE) — Radnor, PA, November 15, 2025 – The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly”) (NASDAQ: FLY) on behalf of those who purchased or otherwise acquired Firefly: (1) common

Class Action Announcement for Firefly Aerospace Inc. (FLY): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Firefly Aerospace Inc.

Class Action Announcement for Firefly Aerospace Inc. (FLY): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Firefly Aerospace Inc. GlobeNewswire November 15, 2025 RADNOR, Pa., Nov. 15, 2025 (GLOBE NEWSWIRE) — Radnor, PA, November 15, 2025 – The law firm of Kessler Topaz Meltzer & Check,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Bancorp, Inc. – TBBK

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of The Bancorp, Inc. ("Bancorp" or the "Company") (NASDAQ:TBBK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bancorp and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hormel Foods Corporation – HRL

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Hormel Foods Corporation ("Hormel" or the "Company") (NYSE:HRL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Hormel and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jefferies Financial Group Inc. – JEF

NEW YORK, NY / ACCESS Newswire / November 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jefferies Financial Group Inc. ("Jefferies" or the "Company") (NYSE:JEF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jefferies and certain of its officers and/or

Scroll to Top